True Wealth Design LLC acquired a new stake in CME Group Inc. (NASDAQ:CME – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 579 shares of the financial services provider’s stock, valued at approximately $128,000.
A number of other hedge funds have also modified their holdings of CME. Ameriprise Financial Inc. increased its position in CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after acquiring an additional 537,758 shares during the period. Raymond James & Associates grew its stake in shares of CME Group by 3.2% in the 2nd quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock valued at $595,530,000 after purchasing an additional 94,302 shares during the last quarter. Legal & General Group Plc increased its holdings in shares of CME Group by 6.6% in the second quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock valued at $557,371,000 after purchasing an additional 176,004 shares during the period. PineStone Asset Management Inc. raised its stake in shares of CME Group by 137.6% during the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after purchasing an additional 1,309,097 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of CME Group by 1.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,981,961 shares of the financial services provider’s stock worth $437,320,000 after purchasing an additional 26,642 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Stock Up 0.3 %
CME Group stock opened at $238.00 on Friday. The firm has a market capitalization of $85.77 billion, a price-to-earnings ratio of 25.03, a price-to-earnings-growth ratio of 5.49 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $238.97. The stock’s fifty day moving average is $225.55 and its two-hundred day moving average is $211.94.
CME Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 1.93%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is 48.37%.
Analysts Set New Price Targets
A number of brokerages have commented on CME. Bank of America upped their price objective on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Piper Sandler increased their price target on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a report on Monday, October 28th. Deutsche Bank Aktiengesellschaft lowered their price objective on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Barclays increased their target price on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 24th. Finally, TD Cowen began coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target on the stock. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $224.47.
Read Our Latest Analysis on CME Group
Insider Transactions at CME Group
In other CME Group news, insider Sunil Cutinho sold 4,500 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the sale, the insider now directly owns 27,053 shares of the company’s stock, valued at $6,131,291.92. This trade represents a 14.26 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now directly owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This represents a 1.57 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 8,028 shares of company stock valued at $1,811,681 over the last three months. 0.30% of the stock is currently owned by insiders.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- How to Invest in Small Cap StocksĀ
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Upcoming IPO Stock Lockup Period, Explained
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.